ACE BEAM: Open Payments
NPI 1962949222 · CULLMAN, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$658 in 34 payments from 12 companies in 2025. Trend: 2023 $559 · 2024 $668 · 2025 $658
Food & beverage: $658
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 4 | $93 |
| PFIZER INC. | 5 | $92 |
| Alnylam Pharmaceuticals Inc. | 5 | $78 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 5 | $77 |
| Novartis Pharmaceuticals Corporation | 2 | $68 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $57 |
| E.R. Squibb & Sons, L.L.C. | 3 | $57 |
| Novo Nordisk Inc | 2 | $45 |
| Philips North America LLC | 2 | $31 |
| LANTHEUS MEDICAL IMAGING, INC. | 1 | $22 |
Products named: VERQUVO, AMVUTTRA, LifeVest, VYNDAQEL, LEQVIO, Kerendia, Wegovy, CAMZYOS.
Industry payments across AL — which companies pay providers there.
